Skip to main content
. Author manuscript; available in PMC: 2014 Jan 7.
Published in final edited form as: Breast Cancer Res Treat. 2008 Mar 9;113(3):10.1007/s10549-008-9953-0. doi: 10.1007/s10549-008-9953-0

Table 3.

Clinical Response

Number of patients 51
Responders 17 (33%)
 Objective response 14 (27%)
 Stable disease 3 (6%)
Non-responders (disease progression) 34 (67%)
PgR + status
 Responders 15 (88%)
 Non-responders 23 (68%)
HER2+
 Responders 7/15 (47%)
 Non-responders 11/30 (37%)